Regulatory Approval Expansion

About Wakunaga Pharmaceutical

Wakunaga Pharmaceutical is a long-established, privately-held Japanese company specializing in OTC pharmaceuticals and health supplements derived from aged garlic extract. Its global strategy is centered on its 'Kyolic' brand, which holds a top market share in the U.S. garlic supplement market and has achieved pharmaceutical approval in Germany for atherosclerosis prevention. The company's business model integrates R&D, manufacturing, and direct-to-consumer marketing through expert counseling, with a mission to contribute to global health and longevity.

Therapeutic Areas